The World Health Organization estimated in 2015 that 80% of neonatal phototherapy devices market preterm infants developed neonatal jaundice a condition that, if untreated, can lead to severe complications, including hyperbilirubinemia, which carries risks of neurological damage or even premature death. As global preterm birth rates climb, especially in regions with limited healthcare resources, neonatal jaundice poses a critical healthcare challenge. In developed countries, preterm birth rates reach up to 7%, with even higher rates observed in developing regions, exacerbating the health risks for infants.
Preterm births have a profound economic impact as well. According to a study published by the National Institute of Health, healthcare costs related to preterm births in the U.S. were estimated at over USD 26 billion in 2005, covering medical expenses and losses in productivity. Asia-Pacific (APAC) and Africa accounted for over 80% of all preterm births in 2005, making infants in these regions especially vulnerable to jaundice-related complications.
In response, neonatal phototherapy treatment, which is essential for managing jaundice and preventing long-term harm, has become a critical need. Expanding access to effective phototherapy options will be pivotal in safeguarding the health of preterm infants worldwide, especially in regions with high birth rates and limited healthcare infrastructure.
Key Market Insights and Highlights:
- High Prevalence of Neonatal Jaundice in Preterm Infants:
- Preterm birth rates reach as high as 7% in developed countries, with even higher rates in developing regions, placing a substantial number of infants at risk.
- A high incidence of jaundice among preterm infants intensifies the need for effective phototherapy treatments to prevent serious health outcomes.
- Economic Burden of Preterm Births:
- According to a National Institute of Health journal, healthcare costs associated with preterm births in the U.S. alone were over USD 26 billion in 2005, factoring in both direct medical expenditures and lost productivity.
- Rising healthcare costs are expected to drive further investment and innovation in neonatal care, particularly in phototherapy treatments that can mitigate long-term health impacts.
- Geographical Disparities in Preterm Birth Rates:
- The Asia-Pacific and African regions account for more than 80% of global preterm births, where limited access to advanced healthcare further increases the risk of neonatal jaundice among preterm infants.
- The disparity in healthcare access and rising preterm birth rates in these regions highlight the urgent need for affordable and accessible phototherapy solutions to address neonatal jaundice.
The Path Forward for Neonatal Phototherapy:
The rising incidence of neonatal jaundice among preterm infants and the substantial costs associated with managing its complications underscore the critical role of neonatal phototherapy treatment. Expanding access to advanced neonatal care, particularly in high-prevalence regions like APAC and Africa, will be essential for reducing the health risks and financial burdens associated with this growing global health concern.
Get Full Report Now
Neonatal Phototherapy Devices Market Taxonomy
Region :
- North America
- US
- Latin America
- Europe
- Germany
- Asia
- China
- India
- Australia
- Middle East and Africa
- South Africa
Product Type :
- Traditional Phototherapy Lamps
- Hospitals
- Home care Settings
- Phototherapy Beds
- Hospitals
- Home care Settings
- Flexible Phototherapy Lamps
- Hospitals
- Home care Settings
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube